NovaBay Pharmaceuticals, Inc. EBIT Growth

EBIT Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Growth growth rates and interactive chart.


Highlights and Quick Summary

  • EBIT Growth for the quarter ending June 30, 2022 was -0.16 (a -72.21% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Growth increased by 43.14%
  • Annual EBIT Growth for 2021 was -0.38 (a -224.48% decrease from previous year)
  • Annual EBIT Growth for 2020 was 0.3 (a -275.22% decrease from previous year)
  • Annual EBIT Growth for 2019 was -0.17 (a 127.02% increase from previous year)
  • Twelve month EBIT Growth ending June 30, 2022 was -0.39 (a -24.26% decrease compared to previous quarter)
  • Twelve month trailing EBIT Growth increased by 419.79% year-over-year
Trailing EBIT Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-0.39 -0.52 -0.38 -0.08
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Growth of NovaBay Pharmaceuticals, Inc.

Most recent EBIT Growthof NBY including historical data for past 10 years.

Interactive Chart of EBIT Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. EBIT Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.16 -0.57
2021 -0.82 -0.11 -0.74 0.01 -0.38
2020 0.21 -0.2 0.22 0.62 0.3
2019 -0.39 0.05 0.34 -0.72 -0.17
2018 -5.11 0.17 -0.19 0.37 -0.08
2017 1.19 -0.05 0.22 0.19 -0.33
2016 0.68 0.61 0.54 0.0 0.48
2015 -0.28 -0.3 -0.28 -0.14 -0.25
2014 -0.01 -0.38 0.09 -0.18 -0.09
2013 -0.71 -27.13 -0.44 -0.4 -0.86
2012 -0.15 0.7 -7.53 -0.28 -0.92
2011 -40.13 0.79 0.04

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology